Biogen Says Growth Products Lifts Revenue, Sees No Impact From Macro Uncertainty

Date:




Biogen first-quarter profit and revenue rose, buoyed by rising sales from its growth products, led by its drug to treat early Alzheimer’s.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related